These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 20854399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Leman J, Burden AD.
    Br J Dermatol; 2012 Nov; 167 Suppl 3():12-20. PubMed ID: 23082811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intermittent treatment regimens and the rational (efficient) use of biologic agents in psoriasis].
    Moreno-Ramírez D.
    Actas Dermosifiliogr; 2011 May; 102(4):241-3. PubMed ID: 21481332
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-TNF-alpha therapy in childhood pustular psoriasis.
    Pereira TM, Vieira AP, Fernandes JC, Antunes H, Basto AS.
    Dermatology; 2006 May; 213(4):350-2. PubMed ID: 17135745
    [No Abstract] [Full Text] [Related]

  • 10. [What is the impact of the new clinical trial data? What are the lessons for patient management?].
    Passeron T, Boulinguez S.
    Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):11-5. PubMed ID: 20510174
    [No Abstract] [Full Text] [Related]

  • 11. Experience with biologics for psoriasis in daily practice: switching is worth a try.
    Lecluse LL, de Groot M, Bos JD, Spuls PI.
    Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876
    [No Abstract] [Full Text] [Related]

  • 12. Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
    Carlesimo M, La Pietra M, Arcese A, Di Russo PP, Mari E, Gamba A, Orsini D, Camplone G.
    Int J Dermatol; 2012 Oct; 51(10):1234-6. PubMed ID: 22416995
    [No Abstract] [Full Text] [Related]

  • 13. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
    Rallis E, Verros CD.
    Dermatol Online J; 2011 Apr 15; 17(4):14. PubMed ID: 21549089
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Consecutive use of different biological therapies in the treatment of psoriasis.
    Costanzo A, Papoutsaki M, Mazzotta A, Chimenti S.
    Br J Dermatol; 2007 Aug 15; 157(2):394. PubMed ID: 17553044
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
    Farnsworth NN, George SJ, Hsu S.
    Dermatol Online J; 2005 Dec 01; 11(3):11. PubMed ID: 16409907
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Tolerance of biological agents in children].
    Bader-Meunier B.
    Arch Pediatr; 2010 Jun 01; 17(6):962-3. PubMed ID: 20654981
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.